Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
FibroBiologics Inc. (FBLG) had Cash Flow from Financial Activities of $4.38M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-4.66M |
|
-- |
|
-- |
|
$4.49M |
|
$-4.49M |
|
$-0.17M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
$-4.49M |
|
$-4.28M |
|
38.63M |
|
38.63M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$10.18M |
|
$0.97M |
|
$3.73M |
|
$13.91M |
|
$10.96M |
|
-- |
|
$2.08M |
|
$13.05M |
|
$0.86M |
|
$0.86M |
|
$0.86M |
|
40.86M |
|
| Cash Flow Statement Financials | |
$-9.26M |
|
$-0.26M |
|
|
Cash Flow from Financial Activities |
$4.38M |
$13.98M |
|
$8.85M |
|
$-5.14M |
|
$1.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.93 |
|
-- |
|
-- |
|
-- |
|
9.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-541.63% |
|
-541.63% |
|
-33.49% |
|
-541.63% |
|
$0.02 |
|
$-0.25 |
|
$-0.24 |
|